Evidence map›Paper›PMID 36320366›Full record

ArticleRadiologia brasileira

Francisco Tustumi, David Gutiérrez Albenda, Rubens Antonio Aissar Sallum, Sergio Carlos Nahas, Ulysses Ribeiro Junior, Carlos Alberto Buchpiguel, Ivan Cecconello, Paulo Schiavom Duarte

Abstract read
In one paragraph

Article in Radiologia brasileira. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francisco TustumiDepartment of Gastroenterology, Digestive Surgery Division, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.ORCID 0000-0001-6695-0496
David Gutiérrez AlbendaDepartment of Radiology and Oncology, Nuclear Medicine Division, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.ORCID 0000-0002-5879-5382
Rubens Antonio Aissar SallumDepartment of Gastroenterology, Digestive Surgery Division, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.ORCID 0000-0003-1823-0042
Sergio Carlos NahasDepartment of Gastroenterology, Digestive Surgery Division, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.ORCID 0000-0002-2268-4146
Ulysses Ribeiro JuniorDepartment of Gastroenterology, Digestive Surgery Division, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.ORCID 0000-0003-1711-7347
Carlos Alberto BuchpiguelDepartment of Radiology and Oncology, Nuclear Medicine Division, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.ORCID 0000-0003-0956-2790
Ivan CecconelloDepartment of Gastroenterology, Digestive Surgery Division, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.ORCID 0000-0002-3535-4170
Paulo Schiavom DuarteDepartment of Radiology and Oncology, Nuclear Medicine Division, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.ORCID 0000-0003-4517-4410

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To evaluate the maximum and mean standardized uptake values, together with the metabolic tumor value and the total lesion glycolysis, at the primary tumor site, as determined by Materials and Methods: The standardized uptake values and the volumetric parameters (metabolic tumor value and total lesion glycolysis) were determined by Results: Eighteen patients (46%) presented RD after nCRT. Statistically significant areas under the curve (approximately 0.72) for predicting RD were obtained for all four of the variables evaluated after nCRT. Considering the presence of visually detectable uptake (higher than the background level) at the primary tumor site after nCRT as a positive result, we achieved a sensitivity of 94% and a specificity of 48% for the detection of RD. Conclusion: The use of

Indexed as

Esophageal neoplasmsNeoadjuvant therapyNuclear medicinePositron-emission tomography

Identifiers

PMID36320366
PMCPMC9620845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.